Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Lack of Effect of Chlordiazepoxide on the Number of Falls in a Novel Falling-Trap Test in Male C57BL/6N Mice

AI Summary
  • Developed falling-trap test to assess falls from an elevated path as a putative index of anxiety-like behaviour; hypothesis that less-anxious mice fall more.
  • Chlordiazepoxide did not significantly increase falls in the falling-trap test, yet significantly increased open-arm time in the elevated plus maze.
  • Under present conditions, number of falls did not support being a measure of anxiety-like behaviour; further studies required to establish reliability and validity.
Summarise with AI (MRCPsych/FRANZCP)

Neuropsychopharmacol Rep. 2026 Sep;46(3):e70161. doi: 10.1002/npr2.70161.

ABSTRACT

Behavioral tests in mice and other animals are widely used to study anxiety and to evaluate the efficacy of anxiolytic compounds. However, the validity of behavioral tests used to assess anxiety-like behavior has been questioned because their results are often inconsistent and not readily replicated across studies. We developed a simple falling-trap test to examine whether the number of falls could serve as an index of anxiety-like behavior. The test is designed to produce falls from an elevated path, based on the hypothesis that less-anxious mice would be more prone to fall. Male C57BL/6N mice were given vehicle or chlordiazepoxide (CDP), and their behavior was evaluated using both the novel test and the elevated plus maze (EPM). The outcomes were the number of falls in the falling-trap test and open-arm time in the EPM. In the falling-trap test, CDP-treated mice did not show a statistically significant increase in the number of falls compared with control mice. In contrast, CDP significantly increased open-arm time in the EPM. Thus, under the present experimental conditions, these findings did not support the hypothesis that the number of falls in the falling-trap test could serve as a measure of anxiety-like behavior. Further studies are needed to determine the conditions under which this assay could be useful and to establish its reliability and validity.

PMID:42599184 | DOI:10.1002/npr2.70161

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review
← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD